Medicine recalls
|
| |
| Canada: Recall: PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidate |
| |
Health Canada announces that Pharmascience Inc. is recalling one lot of PMS-Methylphenidate CR 10 mg capsule (lot number 650529) from retailers because the affected lot exceeds the acceptable intake limit for N-nitroso-methylphenidate (NMPH).
The product is indicated for the treatment of attention-deficit hyperactivity disorder (ADHD).
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/pms-methylphenidate-cr-10-mg-capsule-exceed-acceptable-intake-limit-n-nitroso
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Saturday, Jul 5, 2025
Issued at HKT 12:00
|
| |
